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A cloned, permuted DNA copy of the Abelson murine leukemia virus (A-
MoL V) genome was capable of eliciting the morphological transformation of NIH/ 
3T3 fibroblasts when applied to cells in a calcium phosphate precipitate. The 
efficiency of the process was extremely low, yielding approximately one transform-
~t per microgram of DNA under conditions which give tot transfectants per 
microgram of other DNAs (e.g., Moloney sarconui- virus proviral DNA). The 
DNA was able to induce foci, even though the 3' end of the genome was not 
present. The transforming gene was thus localized to the 5' portion of the genome. 
The transformed cells all produced viral RNA and the virus-specific P90 protein. 
Transmissible virus could be rescued from these cells at very low frequencies by 
superinfection with helper virus; the rescued A-MuLV virus had variable 3' ends 
apparently derived by recombination with the helper. Dimerization of the 
permuted A-MuLV cloned genome to reconstruct a complete provirus did not 
improve transformation efficiency. Virus could be rescued from these transform-
ants, however, at a high efficiency. Cotransfection of the permuted A-MuLV 
DNA with proviral M-MuLV DNA yielded a significant increase in the efficiency 
of transformation and cotransfection of dimeric A-MuLV and proviral M-MuL V 
resulted in a high-efficiency transformation yielding several thousand more 
transformants per microgram than A-MuLV DNA alone. We propose that helper 
virus efficiently rescues A-MuLV from transiently transfected cells which would 
not otherwise have grown into foci. We hypothesize that multiple copies of A-
MoL V DNA introduced into cells by transfection are toxic to cells. In support of 
this hypothesis, we have shown that A-MuLV DNA sequences can inhibit the 
stable transformation of cells by other selectable DNAs. 
Abelson murine leukemia virus (A-MuLV) is a 
replication-defective retrovirus which trans-
forms immature lymphocytes of the B-cell lin-
eage to cause a rapidly progressing lymphosar-
coma (1). In vitro, A-MuLV can cause the 
transformation of primary fetal liver and bone 
marrow lymphoid cells (23) and the fibroblastic 
NIH/3T3 cell line (26). The virus was apparently 
derived by recombination between the parent 
Moloney murine leukemia virus (M-MuLV) and 
a cellular gene, termed C-abl, normally ex-
pressed in lymphoid cells (9, 11, 27). 
The A-MuLV genome consists of a central 
substitution of cellular DNA (V-abl) bracketed 
by regions of homology to the M-MuLV 
genome. The hybrid genome encodes a single 
known protein, which is thought to be responsi-
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ble for the novel transforming activity of the 
virus (21, 38). The protein contains antigenic 
determinants of the parent M-MuLV gag prod-
uct and new determinants encoded by the V -abl 
region. Associated with the Pl20 protein is a 
protein kinase activity, which transfers the gam-
ma phosphate of A TP onto tyrosine residues in 
the Abelson protein itself (35). Viral mutants 
which reduce or abolish this kinase activity also 
reduce or abolish the ability to transform cells 
(24, 36). 
We have previously prepared molecular 
clones of DNA copies of the A-MuL V genome 
and have used these clones to analyze the struc-
ture of the viral DNA and the relationship be-
tween the V -abl region and its cellular homolog, 
C-abl (9). Analysis of the functions of the differ-
ent parts of the A-MuLV genome, however, 
requires an assay for the biological activity of 
these cloned DNAs. In this paper, we describe 
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the successful transfection of these cloned 
DNAs into NIH/3T3 cells to yield transformed 
foci. The efficiency of A-MuLV DNA transfec-
tion was surprisingly low and could be increased 
by procedures that facilitated rescue of virus 
from the initially transfected cell and infection of 
surrounding cells. A portion of the viral genome 
at the 3' end was found to be dispensable for 
transforming activity. Proviruses lacking the 3' 
end of the genome still directed the synthesis of 
viral RNA and proteins. These defective ge-
nomes could be rescued from cells by superin-
fection with helper virus; the recovered viruses 
were recombinants between the A-MuLV provi-
rus and the helper. In this way, a series of new 
A-MuL V genomes could be isolated containing 
variable amounts of helper sequences at the 3' 
end. 
MATERIALS AND MEmODS 
Cells, virus, and DNAs. NIH/3T3 fibroblasts were 
grown in Dulbecco modified Eagle meaium with 10% 
calf serum and were maintained as described else-
where (2). M-MuL V was harvested from clone 1 cells 
constitutively producing virus (8). M-MuL V titers 
were determined by XC plaque assay (25), and A-
MuL V titers were determined by focus formation on 
NIH/3T3 cells (26). Infection of cells by M-MuL V to 
yield producer cells was carried out in the presence of 
8 1-Lg of Polybrene per ml for 2 h at 37°C; virus was 
harvested from producer cells after 12 h. Labeled 
virion RNA was prepared and analyzed as described 
elsewhere (28). 
Clone ~Ab1 and the subclone pAB3Sub3 were as 
described (9). pSV2GPT DNA was a gift of R. Mulli-
gan. Plasmid pAb1Ab1 was prepared by cleavage of 
~Ab1 DNA with Hindiii and by ligation of the result-
ing mixture to Hindiii-cleaved pBR322 DNA (7). The 
product was used to transform Escherichia coli to 
ampicillin resistance, and plasmid DNA was analyzed 
(20) for the presence of A-MuL V DNA. 
Analysis of DNA, RNA, and proteins. The prepara-
tion of total cellular DNA, restriction enzyme diges-
tions, gel electrophoresis, and transfer to nitrocellu-
lose (30) were all as previously described (11). 32P-
labeled probes were prepared by nick translation (22). 
Total cell RNA was prepared by phenol extraction 
oflysates made in the presence of the RNase inhibitor 
vanadyl adenosine (4). Polyadenylate-containing RNA 
was selected on oligodeoxythymidylate cellulose (3) 
and analyzed by electrophoresis through agarose gels 
after denaturation with glyoxal (17). The RNA was 
blotted to diazophenylthio paper and hybridized to 
labeled DNA probes as described elsewhere (32). 
Proteins synthesized by infected cells were exam-
ined by immunoprecipitation of lysates of cells meta-
bolically labeled with [3'S]methionine. The proteins 
were analyzed by gel electrophoresis and tluorography 
as described elsewhere (38). Sera used were goat anti-
Maloney serum (34) and anti-Abelson tumor serum 
(37). 
Transfec:tion of DNAs. Transfection of A-MuLV 
DNA was essentially as described for transformation 
with tumor DNAs (2, 14). Precipitates of calcium 
phosphate and DNA were applied to cells for 4 to 6 h. 
J. VIROL. 
The cells were then trypsinized and replated at a 5: 1 
dilution. Cells were fed every 5 days, and foci were 
counted after 15 to 20 days. Cells transformed by 
pSV2GPT DNA (18) were plated 1 day after transfor-
mation in medium containing (in microgranis per milli-
liter): hypoxanthine, 15; aminopterin, 0.2; thymidine, 
5; xanthine, 250; glutamine, 150; glycine, 5; and myco-
phenolic acid, 25 (19). Colonies were counted after 14 
to 20 days. 
RESULTS 
Biological activity of clone XAbl. We have 
previously described the cloning of circular dou-
ble-stranded DNA copies of the A-MuLV 
genome synthesized soon after infection of 
mouse cells (9). In those experiments, the DNA 
circles were cleaved with Hindlll, and the re-
sulting permuted genomes were joined to the X 
phage vector Charon 21A. The clones were 
derived from a strain of A-MuLV encoding P90, 
a virus-specific transforming protein of 90,000 
daltons. To study the infectivity of the cloned 
DNAs, they were cleaved with Hindiii, ligated 
into polymers, and applied to sensitive NIH/3T3 
cells in a calcium phosphate precipitate (2, 14). 
Even 100 ng of DNA in each of three experi-
ments gave rise in toto to only a single focus 
(TFD-1). Under these conditions, cloned murine 
sarcoma virus DNA (6) gave roughly 104 foci per 
100 ng of DNA (see Table 1). Thus, the A-
MuLV DNA was many orders of magnitude less 
efficient at stable transformation of cells. 
Other transfections were carried out with 
NIH/3T3 cells constitutively producing M-
MuL V as recipient cells. One focus (TFC-1) was 
recovered from a total of three experiments 
(Table 1). Thus, the presence of helper virus in 
these cells did not improve the very low efficien-
cy of the transfection process. A third focus 
(TFA-1) was recovered from transfection of 
these cells without cleavage of the insert from 
vector DNA; excision and polymerization of the 
A-MuL V inserts were apparently not required 
for expression of biological activity. 
Analysis of DNA from transfected cells. To 
confirm that the rare foci recovered in the trans-
TABLE 1. Transformation efficiency of various 
DNAsa 
DNA 
~Ab1 
~Ab1 
~Ab1 
MSVb 
Treatment CeUs 
Cleaved and ligated NIH/3T3 
Cleaved and ligated NIH/3T3/Moc 
NIH/3T3/Mo 
NIH/3T3 
Foci/100 ng 
-0.1 
-0.1 
0.1 
-10" 
a DNAs were applied to the indicated cells in a 
calcium phosphate precipitate, and the foci were 
counted. Numbers are the averages of 5 to 10 experi-
ments. 
b MSV, Murine sarcoma virus. 
c NIH/3T3/Mo denotes NIH/3T3 cells chronically 
infected with Moloney murine leukemia virus. 
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fection experiments were authentic transfor-
mants, the cellular DNA from the transfectants 
and normal NIH/3T3 cells was tested for the 
presence of new A-MuL V sequences. Total cel-
lular DNA was isolated, cleaved with several 
restriction enzymes, blotted onto nitrocellulose 
paper, and probed with an ab/-specific probe (9). 
Normal NIH/3T3 cell DNA contains a large 
region of homology to this probe-the endoge-
nous C-ab/ gene-which, after BamHI, Hindiii, 
or EcoRI digestion, gives rise to a variety of 
fragments (Fig. lA and B, 3T3 lanes; endoge-
nous bands are relatively faint because the gel 
was exposed to show the intensity of the bands 
in the transfected cells). Digests of the DNA 
from each transfected line with these enzymes 
revealed the C-abl fragments and in addition 
either one or two new fragments which labeled 
very intensely (Fig. lA and B). Therefore, these 
foci contained new DNA homologous to the abl 
sequence. The enzymes used did not cleave 
within the region of the A-MuLV genome con-
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tained in the abl probe. Thus, the number of new 
bands seen indicated directly the number of 
distinguishable copies of the A-MuL V genome 
introduced into the cells. The very high intensity 
of hybridization seen suggested that the new 
DNA was present at an amplified level of 5 to 10 
copies per cell, as has been observed for other 
transfected DNAs (12). 
Cleavage with the enzyme Xbal suggested 
that these new A-MuLV DNAs were not the 
result of conventional viral infection. Xbal 
cleaves within the long terminal repeat (LTR) 
sequences which bracket normal pro viruses (9); 
thus, it releases from authentic proviruses a 
fragment whose length is characteristic of the A-
MuLV genome. Analysis of the Xbal-cleaved 
DNA from the three foci revealed fragments of a 
size different from that ofthe 5.6-kilobase provi-
ral DNA (Fig. 2). Similar results were obtained 
after cleavage with Kpnl and Sacl, enzymes 
which also cleave in the LTR sequences (9) (data 
not shown). We concluded that the A-MuLV 
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FIG. 1. Analysis of viral DNA in three cell lines transfected with cloned A-MuLV DNA. Total cellular DNAs 
from NIH/3T3 cells and three transformed cell lines were cleaved with the indicated restriction enzymes, 
fractionated by agarose gel electrophoresis, hybridized with labeled DNA probes, and exposed to X-ray film. (A 
and B) DNAs were probed with an A-MuLV-specific probe; transformed cells contained new viral DNA in 
addition to the endogenous C-abl sequences found in 3T3 cells. (C) Radioactivity was washed from the filter 
shown in (B), and the filter probed with a phage lambda DNA probe. The bands common to all lanes are due to 
trace amounts of EcoRI-cleaved lambda DNA added as marker after digestion of the cell DNA. These cell lines 
contain one and two lambda DNA-containing fragments. In no case are these fragments the same as the virus-
containing fragments detected in B. 
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FIG. 2. Analysis of structure of proviral DNA in two cell lines transfected with cloned A-MuL V DNA. Cell 
DNA was cleaved first with Xbal to provide a fixed endpoint in the LTR sequence and then with a variety of 
enzymes recognizing sites further downstream in the viral genome. The viral fragments were detected by 
hybridization to the 32P-labeled A-MuLV-specific DNA probe. A summary of the structures is given in Fig. 6. 
DNA in these cells was apparently not bracket-
ed by the two L TRs that flank normal proviral 
DNA. Cleavage with Xbal plus other enzymes 
revealed that sites in the 5' half of the A-MuLV 
genome were present (Fig. 2) but that sites in the 
3' half were missing. 
Further proof that the cells were transfected 
could be obtained by testing for the presence of 
vector phage lambda DNA in the cell DNA. 
Although no selection for the vector DNA was 
applied, mixed DNAs are commonly acquired 
by the same cell (33). Reprobing the same blot 
shown in Fig. 1A showed that lambda DNA 
fragments were indeed present in these cells 
(Fig. 1C; the common bands in the lanes were 
due to added ~ phage DNA used as marker, 
whereas the individual bands were due to trans-
fection). Any focus deriving from a viral con-
tamination would be unlikely to carry lambda 
DNA. 
Expression of viral gene products by transfect· 
ed ceUs. To examine whether the transfected 
cells expressed A-MuL V gene products, cellular 
RNA and proteins were analyzed. Total cell 
RNA was isolated from cultures of two cell 
lines. This RNA was separated by electrophore-
sis through an agarose gel, transferred to diazo-
tized paper, and hybridized with an ab/-specific 
probe. Autoradiography revealed large amounts 
of viral RNA (Fig. 3). In one case (lane TFC-1), 
the RNA seemed heterogeneous in size even 
with shorter autoradiographic exposures, 
whereas in another (lane TFA-1), RNAs of two 
discrete sizes were detected. The amounts of 
virus-specific RNA in the transfected cells were 
as much as or greater than that found in virus-
infected cells (lane ANN-1). No discrete RNA 
identical in size to that of authentic viral RNA 
was detected. Major bands both larger and 
smaller than viral RNA were found. 
The transfected cells were analyzed for the 
presence of the A-MuLV-encoded P90 protein 
by metabolic labeling with [3sS]methionine and 
immunoprecipitation with sera specific for the 
gag determinants or with anti-Abelson tumor 
serum (37). All three cell lines produced a P90 
protein (two are shown in Fig. 4). Those lines 
derived by transfection of M-MuL V producer 
cells also contained the expected helper proteins 
Pr80""v and Pr65gag 0 
Recovery of transmissible virus. Because the 
viral DNA contained in these transfected cells 
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FIG. 3. Analysis of viral RNA in cells transfected 
with A-MuLV DNA. Equal amounts of RNA isolated 
from the virus-infected cell line ANN-1 and cells 
transfected with A-MuLV DNA were fractionated by 
electrophoresis, blotted to diazotized paper, and hy-
bridized with a radioactive A-MuLV-specific probe. 
was not a complete provirus bracketed by two 
LTRs, the viral RNA produced should not be 
transmissible by conventional mechanisms. 
Nevertheless a low but measurable titer of A-
MuL V focus-forming units was produced by 
those transfected cells which contained helper 
virus. Supernatant culture ftuid from these cells 
had approximately 106 XC PFU/ml, but had 
focus-forming titers of approximately 1 focus per 
ml (Table 2). Several of the rare secondary foci 
were picked from plates infected by the virus 
liberated from the primary transfected cells and 
were grown into large-scale cultures. The major-
ity of these secondary cell lines released high 
titers of both helper M-MuLV and focus-forming 
A-MuLV (Table 2). Thus, during the rescue of 
A-MuLV from the primary focus to produce the 
secondary foci, some event had restored the 
transmissibility of the virus to its normally high 
level. These results were similar to the rescue of 
defective Harvey sarcoma virus reported by 
Goldfarb and Weinberg (13) and suggested that, 
as in the Harvey sarcoma virus system, restora-
tion of transmissibility might have occurred by 
restoration of the missing 3' end of A-MuL V by 
recombination with the helper M-MuLV. A few 
secondary foci (A12, A14, and C6) were M-
MuL V producers but were rather low-level pro-
ducers of A-MuL V. These rare foci apparently 
did not contain easily transmissible proviruses. 
Structure of rescued A-MuLV: isolates with 
new genomic sizes. To examine the structure of 
the rescued A-MuLV genomes, DNA was isolat-
ed from each of 23 secondary foci and the 
structure of their A-MuLV proviral DNA was 
determined. Total cellular DNA was cleaved 
with each of three enzymes-Xbal, Kpnl, and 
Sacl-and the cleaved DNAs were displayed by 
agarose gel electrophoresis and probed by hy-
bridization with the abl probe as before. All of 
these enzymes cleave at known locations in the 
5' portion of the A-MuLV genome. The sizes of 
the A-MuLV-containing DNA fragments pro-
duced by these enzymes thus defined the posi-
tion of the new sites at the 3' end of the provirus. 
New sites for cleavage by Hindiii and BamHl 
were also determined by analyzing double di-
gests with Xbal plus Hindiii and with Sacl plus 
BamHl, respectively. Examples of several of 
these analyses are shown in Fig. 5. The new 
sites at the 3' end of the A-MuLV proviruses 
align perfectly with known sites in M-MuLV for 
nearly all of the clones analyzed (20 of 25 
proviruses). The position of these sites could 
thus be used to define the position and extent of 
the new M-MuLV sequences at the 3' end. The 
mapping data are summarized in Fig. 6. 
The total sizes of the new, rescued genomes 
varied widely: genomes were found which were 
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FIG. 4. Analysis of viral proteins in cells transfect-
ed with A-MuL V DNA. CeUs were metabolically 
labeled with [35S]methionine and the virus-specific 
proteins extracted, immunoprecipitated with specific 
antisera, separated by polyacrylamide gel electropho-
resis, and detected by ftuorography. M: goat anti-
Moloney serum was used. A: Abelson murine tumor 
regressor serum specific for the A-MuLV-encoded 
protein was used. 
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TABLE 2. Virus expression by primary transfectants and secondary transformants 
Source• RT' M-MuLV P90 Released focus-Cell Line proteins< forming units per ml 
Primary 
0 TFD-1 ~bl-+ 3T3 + 
TFA-1 AAbl -+ 3T3/Mo (uncut) + + + 0.5-1 
TFC-1 AAbl -+ 3T3/Mo + + + 0.5-1 
(cut and ligated) 
TFE-1 pAblAbl -+ 3T3 + 0 
TFE-1/M Superinfection of TFE-1 + + + >10" 
TFB-1 AAbl + pZAP -+ 3T3 + + + >10" 
TFB-2 AAbl + pZAP-+ 3T3 + + + >10" 
TFB-3 AAbl + pZAP -+ 3T3 + +d + >104 
TFB-4 ~bl + pZAP -+ 3T3 + +d + >10" 
TFB-5 ~bl + pZAP -+ 3T3 + +d + >10" 
Secondary 
2 X lOS Al TFA-1 + + + 
A3 TFA-1 + +d + 2 X 10" 
A4 TFA-1 + + + 6 X 10" 
A5 TFA-1 + + + 4 X 104 
A6 TFA-1 + + + 4 X llf 
AS TFA-1 + + +· 2 X 103 
A9 TFA-1 + + + 6 X llf 
All TFA-1 + +~ + 3 X llf 
Al2 TFA-1 + +d Very low 6 X 101 
Al4 TFA-1 Very low +d + 1 X 102 
+d 3 X 104 Cl TFC-1 + + 
C2 TFC-1 Low + + 4 X llf 
C3 TFC-1 + +d + 2 X lOS 
C4 TFC-1 + +d + 2 X 10" 
C5 TFC-1 + +d + 4 X 104 
C6 TFC-1 + + + 1 X 1Q2 
C7 TFC-1 + +d + 2 X 103 
cs TFC-1 + + Very low 2 x llf (late) 
C9 TFC-1 + + + 5 X llf 
ClO TFC-1 + + + 2 X 10" 
Cl2 TFC-1 + + + 1 X 10" 
Cl3 TFC-1 + + + 2 X 103 
Cl4 TFC-1 + + + 5 X 103 
a The DNA or mixture of DNAs and the cell line used in the transformation are given. 
b The results of the rapid reverse transcriptase assay are given (11). 
c Cells containing Pr65gag and PrSO"nv intracellularly as determined by gel electrophoresis are denoted as + ; 
those not expressing detectable levels of these proteins are denoted as -. 
d These cell lines contained in addition to the expected M-MuL V proteins a protein of 110,000 daltons 
immunoprecipitated by the goat anti-Moloney serum. 
• This cell line contained in addition to the A-MuLV P90 protein a novel protein of 85,000 daltons 
immunoprecipitated by both the goat anti-Moloney and anti-Abelson tumor sera. 
as short as 5.0 kilobases and as long as 9.8 
kilobases. In some cases (clones Cl, C2, C3, C7, 
C8, C9, and C14), the Hindiii site present at the 
3' end of the A-MuLV DNA in the primary focus 
had been carried over into the secondary foci. 
Thus, the recombination which appended the 
helper sequences must have occurred to the 
right of the Hindiii site in the primary provirus. 
In other cases (clones C4, C5, and C12), this site 
was lost, suggesting that the recombination oc-
curred to its left. The length of the A-MuLV 
genome that was rescued was therefore variable. 
Similarly, in some cases many sites in the M-
MuLV genome were present in the restored 3' 
end, whereas in other cases only sites derived 
from the M-MuLV LTR were found. Thus, 
variable amounts of helper sequences had been 
appended. It is likely that many sites within both 
the A-MuLV parent and the M-MuLV helper 
can be utilized for recombination. The require-
ment for recombination between the helper virus 
and the truncated A-MuLV to give rise to the 
secondary foci presumably accounts for the low 
titer of focus-forming units released by the pri-
mary foci. Once this recombination has oc-
curred, a fully transmissible virus is produced. 
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FIG. 5. Analysis of proviral DNA in cell lines infected with virus rescued from transfected cells. DNA was 
isolated, fractionated, and blotted as described in Fig. 1. Proviral DNAs were detected by hybridization with a 
labeled A-MuLV-specific probe. A: DNAs of the indicated cell lines were digested with Xbal (X), Xbal and 
Hindlll (X + H), or Hindlll (H) before eiectrophoresis. Each line contained the fragments expected from the 
endogenous C-abl gene (marked C for Xbal and Hindiii digests) plus a new proviral band (marked V for the 
outer lanes). 8: DNAs of the indicated cell lines were digested with Sacl. Each line contained the endogenous C-
ab/ fragments (C) and one new proviral fragment of variable size. The provirus of line C5 comigrates with an 
endogenous fragment. C: DNAs were digested with Kpnl. Each line contains the expected endogenous 
fragments (C) and a new provirus. The provirus of line A14 comigrates with an endogenous fragment. 
To examine the number of proviruses in sec-
ondary transformants, cleavage with Hindiii 
was used. This enzyme released one to three 
new fragments containing A-MuL V sequences 
from the DNA of secondary foci (Fig. 5A). 
Because Hindiii does not cleave in the LTR, 
each integrated provirus should give rise to one 
fragment labeled by the A-MuL V probe whose 
size will vary depending on the flanking cellular 
sequences. Because the number of fragments 
seen will be a measure of the number of provi-
ruses, from one to three proviruses are present 
in the cells of each secondary focus (Fig. 6). 
Because cleavage with enzymes which cut in the 
LTR gave only one size of DNA, the multiple 
proviruses in any given clone were apparently 
identical to one another. These multiple provi-
ruses probably result from rescue of the initially 
infecting A-MuL V genome by the excess helper 
M-MuL V and then self-infection before the su-
perinfection barrier appears (D. Steffen and R. 
Weinberg, unpublished data). There were two 
exceptions to this pattern (clones A9 and ClO). 
In each of these lines, two different kinds of 
provirus were found. 
A minority of the secondary foci (clones A14, 
C6, C8, ClO, and C13) apparently contained A-
MuLV DNA which had not simply recombined 
with helper sequences. Cleavage of DNA from 
these cells by the three enzymes used did not 
yield positions consistent with the known loca-
tion of these sites in the M-MuL V genome. The 
location of the 3' L TR is thus uncertain in these 
proviruses. Possibly, the A-MuLV has recom-
bined with aberrant helper M-MuLV sequences 
or has suffered secondary rearrangements after 
recombination. Alternatively, helper sequences 
may not have been appended at the 3' end at all. 
The restriction sites mapped to date on these 
rare aberrant clones are shown in Fig. 7. It 
should be noted that two of these rare cell lines 
(clones A14 and C6) are rather low level produc-
ers of A-MuL V (Table 2). Thus, the A-MuL V 
provirus may have been transmitted to these 
secondary foci without complete repair of the 3' 
end. Some of these lines, however, do release 
high titers of A-MuLV and presumably have a 
functional (though aberrant) 3' end. 
The size of the new A-MuL V genomes was 
also determined by an independent test. The 
secondary cell lines were metabolically labeled 
with 32Pi> and the labeled virions released into 
the medium were purified. The virion RNA was 
isolated and analyzed by electrophoresis 
through agarose gels after denaturation with 
glyoxal. Autoradiography (Fig. 8) revealed the 
presence of new RN As of variable length, along 
with the expected M-MuL V RNA, 30S viral 
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FIG. 6. Structure ofproviruses in each of two transfected cell lines (TFA-1 and TFC-1) and in each of20 lines 
derived by infection with virus rescued from these two transfected lines. The position of the new restriction 
cleavage sites at the 3' end are shown. Because an abl probe was used as described in Fig. S, only the cleavage 
sites nearest to the abl sequence were evident from the analysis. The X hal, Kpnl, and Sacl sites mapping within 
the new 3' L TR have been left out for clarity. The position of the new 3' L TR (deduced from the position of these 
sites) is indicated by a box. The minimum extent of the new M-MuLV sequences (determined by the position of 
new, previously mapped M-MuLV restriction sites) is indicated by the shaded region. Note that the Xbal and 
Kpnl sites in C3 are different ones from those found in other clones but these sites are known to be present in the 
M-MuLV sequence. The number of identical proviruses in each cell line is indicated. The genome size in 
kilobases as deduced from the DNA structure, extending from positions in the left L TR to the equivalent position 
in the right LTR, is indicated. The viral RNA size, as measured directly on agarose gels (see Fig. 8), is indicated. 
N.D., Not determined. 
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FIG. 7. Structure of aberrant proviruses in each of six lines derived by infection with virus rescued from two 
transfccted lines. The DNAs were analyzed as in Fig. 6. The restriction sites mapped are shown; no LTR can be 
placed on these maps. The sizes of the viral RNAs released by the cell lines are shown. 
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FIG. 8. Analysis of virion RNAs released by in-
fected cell lines. After cells were metabolically labeled 
with 32Pit virion RNA released into the medium was 
purified and analyzed by electrophoresis in agarose. 
Each cell line released particles containing a viral RNA 
of variable size along with the expected M-MuL V 
RNA, 30S virus-related RNA, and contaminating 
rRNA's. 
RNAs (5, 15) and contaminating rRNA's. The 
size of the new RNA was in good agreement 
with the provirus DNA size contained in that 
cell line (Fig. 6). In some cases (clones A12, C1, 
C8, and C10), multiple new RNAs of several 
sizes were detected. The origin of these multiple 
RNAs is not known. Many of the cell lines 
containing aberrant proviruses (with unknown 
genome size) made multiple new RNAs. 
The proteins produced by the secondary foci 
were also examined by immunoprecipitation 
with sera (anti-Abelson tumor and goat anti-
Moloney) specific for A-MuLV and M-MuLV 
proteins (Fig. 9). All of the clones produced the 
expected M-MuL V proteins because they were 
producer cells. Most synthesized the A-MuLV-
specific P90 protein as well (Table 2), although 
the level of protein detected was variable; in 
some clones (clones C8 and A12), the amount 
was very low. Several clones seemed also to 
produce a protein of approximately 110,000 dal-
tons which was precipitated by the goat anti-
Moloney serum and not by the anti-Abelson 
tumor sera (Fig. 9). The nature of this protein 
has not been determined. 
lllgh-efliclency fl'allsfection by A-MuLV DNA. 
Although a few foci could be recovered by direct 
transfection of cloned A-MuLV DNA, the effi-
ciency of the process was extremely low. We 
therefore sought to modify the DNA structure to 
enhance the transfection frequency. 
The A-MuLV insert present in ~Ab1 was 
excised by cleavage with Hindiii and ligated to 
Hindiii-cleaved DNA of the plasmid vector 
pBR322 (7). The resulting DNA was introduced 
into competent bacterial cells, and ampicillin-
resistant colonies were selected. Plasmid DNA 
from most of these clones showed a single copy 
of the A-MuL V insert in pBR322; these clones 
showed biological activity in animal cells similar 
to the original ~Ab1 clone (data not shown). One 
plasmid was recovered which consisted of a 
head-to-tail tandem dimer of Ab1 DNA inserted 
into a single pBR322. This plasmid, termed 
pAb1Ab1, thus contained a full size A-MuLV 
DNA genome. 
Transfection of NIH/3T3 cells with this dim er-
ic DNA was no more efficient than with the 
monomeric, permuted DNAs (Table 3A). Thus, 
reconstruction of the missing 3' terminus did not 
measurably increase the low transfection effi-
ciency because only one clone (TFE-1) was 
recovered from several transfections, each using 
100 ng of DNA. Analysis of the viral DNA in 
this clone suggested that a complete provirus, 
from 5' LTR to 3' LTR, had been introduced. 
Cleavage with all enzymes with sites in the 
L TRs released fragments whose sizes were in-
dicative of a normal proviral structure (Fig. 2). 
Viral RNA was also detected in these cells (Fig. 
3) some of which comigrated with authentic viral 
RNA. The cells of this focus were nonproduc-
ers. After superinfection with helper M-MuLV 
virus, the cells became high level producers of 
M-MuLV and, significantly, also high-level pro-
ducers of A-MuLV (Table 2). Thus, A-MuLV 
DNA which was introduced into cells by trans-
- 10 U> 
u u w 
MAMAMA 
-P90 
- Pr80env 
-Pr6511°9 
(X) 
u 
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FIG. 9. Analysis of viral proteins synthesized by 
infected cell lines. Proteins were immunoprecipitated 
and detected as in Fig. 4. M: goat anti-Moloney MuL V 
serum. A: mouse anti-Abelson tumor regressor serum. 
Each line contains the M-MuL V -specific proteins 
Pr65•a• and Pr80'"" and the A-MuLV-specific P90. 
(Cell line C8 has very little P90.) 
280 GOFF ET AL. 
fection could be directly rescued at a high level 
by helper virus when a complete provirus was 
present. This result lends further support to the 
notion that repair of the 3' end missing in 
transfectants TF A-1 and TFC-1 is responsible 
for the low but significant level of A-MuL V 
rescuable from these lines. 
Because modification of the cloned DNA did 
not appear to increase its transfectability we 
turned to cotransfection of the intact ~Abl DNA 
with a biologically active M-MuLV proviral 
clone termed pZAP (29). This yielded a consid-
erable improvement in transformation efficien-
cy. In one experiment, 100 ng of A-MuL V DNA 
yielded five foci (Table 3). Because helper virus 
was spreading throughout the culture, the trans-
fectants were expected to be producers of M-
MuLV; they might also have been producers of 
A-MuL V. Analysis of the virus harvested from 
individual foci (Table 2; TFB clones) showed 
that all were in fact high producers of both M-
MuLV and A-MuLV. Analysis of the proviral A-
MuLV DNA in these cultures (Fig. 10) showed 
that several proviruses were present in the DNA 
of each clone, and that an L TR had apparently 
been appended to the 3' end of each A-MuLV 
genome. At least some of the integrated DNAs 
had genomes of different lengths, suggesting that 
independent recombinational events had given 
rise to these genomes. The five clones, there-
fore, did not all arise by virus spread from a 
single producer cell. These transfectants were 
probably equivalent to the secondary foci de-
rived earlier; helper virus had rescued the A-
MuLV from rare transfectants, repaired the 3' 
end in one of several ways, and passed the 
genomes to the cells finally recovered as foci. 
Thus, transfection, repair, and rescue of A-
MuLV can be combined in a single operation by 
the addition of helper M-MuLV DNA to the 
J. VIROL. 
transfecting A-MuLV DNA. The total efficiency 
of the process, however, was still low. 
A very high efficiency of transfection was 
finally obtained by combining cotransfection 
with the use of rescuable A-MuLV cloned DNA. 
Dimeric A-MuLV DNA (such as pAb1Ab1), 
when mixed with helper M-MuLV DNA (such 
as pZAP), was capable of inducing transforma-
tion of cells at high efficiency (Table 3A). Typi-
cally, hundreds to thousands of foci were ob-
tained with quantities of DNA (100 ng) which, 
without helper DNA, rarely gave even one fo-
cus. The helper DNA probably acted to pass the 
A-MuLV genome to new cells by infection, 
because cells which were previously infected 
with M-MuLV and therefore resistant to infec-
tion because of surface interference could not be 
transformed at this high level. Such cells, how-
ever, could be transformed by other selectable 
markers at control levels (Table 3A). 
The large number of foci appeared very early 
after transfection (visible in less than 10 days) 
and were not localized near a large focus in the 
way that secondary foci normally surround a 
primary focus. The hundreds of foci thus did 
not seem to have spread from a rare transform-
ant. To test this point more carefully, the A-
MuL V was diluted and titrated in the presence 
of a constant amount of M-MuL V DNA (Table 
3B). The number of foci observed showed a 
linear response to dilution of the A-MuLV 
DNA. Moreover, many foci were recovered 
with very small amounts of A-MuLV-far less 
than had given one focus in the absence of 
helper DNA. Thus, helper DNA did not merely 
spread A-MuL V from those rare cells which 
would have grown to foci; it rescued A-MuLV 
from many cells which otherwise would not 
have been stably transformed. 
Two other full-length clones of the A-MuL V 
TABLE 3. Number of foci produced by transfection of various forms of A-MuLV DNA 
A. DNA Helper DNA" Recipient ceUs Foci/100 ng 
~Ab1 NIH/3T3 -0.1 
pAb1Ab1 (dimer) NIH/3T3 -0.1 
~b1 pZAP NIH/3T3 5 
~b1 cleaved and ligated pZAP NIH/3T3 42 
pAb1Ab1 (dimer) pZAP NIH/3T3 600,650 
pAb1Ab1 (dimer) pZAP NIH/3T3/Mob 0.5, 0.3 
pSV2-gpt NIH/3T3 150 pSV2-gpt NIH/3T3/Mo 138 
B. DNA Amt (ng) Helper DNA• Foci 
pAb1Ab1 (dimer) 300 pZAP >1,000 pAb1Ab1 (dimer) 100 pZAP 594 
pAb1Ab1 (dimer) 30 pZAP 191 
pAb1Ab1 (dimer) 10 pZAP 65 
• A fixed amount (800 ng) of pZAP DNA (plasmid DNA containing a complete M-MuL V provirus) was used as 
helper where indicated. 
b NIH/3T3/Mo denotes NIH/3T3 cells chronically infected with Moloney murine leukemia virus. 
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FIG. 10. Analysis of A-MuLV proviruses in cells 
transfected with a mixture of permuted A-MuLV DNA 
and proviral M-MuL V DNA. DNAs were fractionated 
after cleavage with Xbai (X) or Hindiii (H) and 
hybridized with an A-MuLV-specific probe. In addi-
tion to endogenous C-abl fragments (C), each line 
contains several proviruses (detected as new bands in 
the Hindiii digests). Many lines contain proviruses of 
dilferent sizes (as determined by bands in the Xbai 
digests). 
genome (>.Ab3 and >.Ab4) which were previously 
isolated (9) were retested for biological activity 
under the conditions giving a high efficiency of 
transfection. No foci were observed. In addi-
tion, clones of a transformation-defective vari-
ant of A-MuLV (clones >.Ab2, >.Ab7, and >.Ab8) 
were similarly inactive. 
Inhibition of gene transfer by A-MuL V DNA. 
The low frequency of direct transformation by 
the A-MuLV genome might be due to a low 
frequency of uptake, integration, or expression 
of the DNA. Alternatively, when the DNA is 
introduced by transfection, but not by infection, 
the DNA itself or the expression of gene prod-
ucts encoded by the DNA might be toxic to cells 
and prevent the outgrowth of a transformed 
focus. To examine these possibilities, the effect 
of A-MuLV DNA on transfer of a selectable 
gene was determined. A fixed amount of the 
selectable marker carried by a simian virus 40-
E. coli xanthine-guanine phosphoribosyltrans-
ferase gene chimera (pSV2-gpt; reference 18) 
was mixed with test DNAs and applied to NIH/ 
3T3 cells. Transformed colonies were detected 
by their resistance to mycophenolic acid (19). In 
one experiment (Table 4), 1 J.Lg of pSV2-gpt 
DNA alone gave rise to hundreds of colonies; 
addition ofpBR322 DNA caused at most a slight 
reduction in the efficiency of stable transforma-
tion. Addition of an equivalent amount of A-
MuLV DNA dramatically reduced the number 
of colonies detected. Thus, A-MuL V DNA or its 
gene products can apparently act in trans to 
prevent stable transformation of cells by another 
selectable DNA. 
DNA of a very similar but biologically inac-
tive clone (>.Ab3) did not inhibit transformation 
of cells by pSV2-gpt. Moreover, cleavage of the 
biologically active clone (>.Ab1) to small frag-
ments by Pstl also destroyed the inhibition 
activity of this clone (Table 4). Thus, the expres-
sion of A-MuL V transforming activity appears 
responsible for inhibition of transformation. 
This inhibition is apparently an effect of the 
biologically active gene products of the A-
MuLV DNA and not of the DNA itself. 
DISCUSSION 
Transfection with A-MuL V DNA. Of three full-
length clones of the A-MuLV genome previous-
ly isolated (9), one was found to be biologically 
active, whereas two apparently indistinguish-
able clones were not. These inactive clones 
probably harbor point mutations or other unde-
tected alterations which affect the expression of 
the transforming gene. This mutation frequency 
(2/3) is in agreement with the high levels of 
mutation noted for retrovirus replication (10, 28) 
and is also comparable to that seen in clones of 
M-MuLV (unpublished observations) and of an-
other strain of A-MuLV encoding the larger 
P160 transforming protein (S. Latt, personal 
communication). 
The insert in the active clone >.Ab1 was per-
muted relative to the normal integrated provirus 
of A-MuL V because it was prepared by Hindiii 
cleavage of a circular replication intermediate. 
Hindiii cleaves 3' to the region encoding the P90 
transforming protein (11) and thus the LTR 
region (which carries the promoter for transcrip-
tional initiation), the gag region, and the coding 
portion of the abl region were all retained in 
their normal order in the permuted clones. This 
presumably allowed the cloned DNA to retain 
its ability to transform cells. 
The active clone also contained two tandem 
copies of the L TR because it was derived from a 
circular intermediate containing two LTRs (9). It 
is not known whether the two LTRs are neces-
sary or helpful for biological activity. In other 
experiments with M-MuLV clones (unpublished 
data), we have found no difference between the 
activity of clones carrying one or two L TRs. 
Direct transfection with the permuted A-
MuLV DNA yielded a few foci which carried A-
MuL V DNA. The viral DNA in these cells was 
incomplete; analysis of the restriction sites sur-
rounding the viral DNA suggested that the 3' 
end of the genome was missing. Thus, the 3' 
untranslated end of A-MuL V was apparently not 
required for morphological transformation. In 
fact, restoration of the 3' end to the transfecting 
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TABLE 4. Inhibition of transformation by A-MuLV DNAs 
Expt no. 
1 
2 
Selected DNA• 
pSV1-gpt 
pSV2-gpt 
pSV2-gpt 
pSV2-gpt 
pSV2-gpt 
pSV2-gpt 
pSV2-gpt 
pSV2-gpt 
pAb1Ab1 
pBR322 
pAb1Ab1 
pAb1Ab1 cleaved 
by Pstl 
AAb3 
pBR322 
Colonies/1 00 ng 
of selected DNA 
0 
94 
5 
54 
0 
47, 55 
8, 4 
55,54 
38,48 
61,43 
a A fixed amount (100 ng) of the selectable DNA was used. 
b One microgram of the cloned A-MuLV was used; an equivalent amount on a molar basis of pBR322 DNA 
(260 ng) was used. All points contained 75 11-8 of carrier DNA. 
DNA by dimerization of the insert (Table 3) did 
not improve the transfection efficiency. Appar-
ently, sequences which are randomly appended 
to the 3' end of the incomplete provirus during 
the transfection process do not block expression 
of the virus, because large amounts of virus-
specific RNA and virus~encoded P90 protein 
were detected in these cells. It is not clear 
whether any special sequences were selected by 
the need for expression of the partial A-MuLV 
genome. 
Only one or two distinct DNA fragments 
containing the A-MuLV DNA were found in the 
primary foci; the high intensity of hybridization 
suggested that these fragments were present at 
greater than a single copy per haploid genome. 
Thus, as has been observed in other systems 
(12), the transfected DNA was apparently ampli-
fied in such a way as to preserve the flanking 
sequences. The very high copy numbers (greater 
than 100) occasionally found after transfection 
with <I>X DNA and the thymidine kinase gene 
(33) were not observed with A-MuL V DNA. 
In at least two cases, the lambda phage vector 
DNA was also carried into the cell and became 
stably associated with the cellular DNA (Fig. 1). 
This was found whether or not the A-MuL V 
insert was excised from the vector DNA. How-
ever, the lambda DNA in these cells was never 
so closely linked to the A-MuL Vas to be joined 
on the same restriction fragment. The lambda 
DNA did not stay joined even when the DNA 
applied to the cells was uncleaved (focus TFA-1, 
Fig. 1). Thus, in our cells, the transfecting DNA 
is apparently fragmented and subsequently 
joined to new DNAs at random before becoming 
stably associated with the cell DNA. 
Rescue of defective proviruses. A-MuL V par-
tial genomes could be rescued from the primary 
foci by helper virus. In most cases, it could be 
demonstrated that rescue was accompanied by 
restoration of the 3' end of the genomes; M-
MuLV DNA (at least three different restriction 
sites in the DNA) was appended to a portion of 
the A-MuLV genome. Apparently new se-
quences were appended by recombination with 
the helper M-MuLV, as was first shown by 
Goldfarb and Weinberg (13) for the rescue of 
partial proviruses of Harvey sarcoma virus. The 
new A-MuLV genomes created by the recombi-
nation had various sizes, ranging from 5.0 to 9.8 
kilobases in length. In addition, the amounts of 
A-MuLV and ofM-MuLV present in the recom-
binant were variable. In some cases, all of the 
available A-MuLV DNA and at least some of the 
3' flanking sequences were probably incorporat-
ed into the recombinant; in other cases, not even 
all of the permuted A-MuL V genome was pres-
ent. Once recombination had occurred, the new 
genomes were capable of normal high-efficiency 
transfer to new cells mediated by helper virus. 
Several of the new genomes were extremely 
large, even larger than the helper RNA, and 
were nevertheless capable of being packaged 
into virions and transmitted to new cells. These 
observations extend the known upper limit for 
packaging by murine retrovirus virions to nearly 
10 kilobases. Some of these larger genomes 
contain a complete env gene and thus might be 
capable of helper-independent expression of 
Prsoenv. Experiments are in progress to analyze 
further the proteins encoded by these large 
viruses. 
All of these viruses encode the A-MuLV-
specific P90 protein rather than the full-length 
P120 protein because they were derived from a 
strain encoding the shortened protein P90 (9); 
the P90A strains contain a point mutation or 
other small alteration causing early translational 
termination (11). The sequences immediately 
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following the termination site for P90 are un-
changed and thus code for the extra 30,000 
daltons of protein present in P120 and missing in 
P90. In the clone containing the least A-MuL V 
DNA (clone C4), the amount of the abl region 
present was barely able to encode the ab/-
specific portion of the wild-type P120 protein. 
We can be certain, therefore, that the down-
stream sequences (after the C-terminus of the 
P120) are not needed for transformation of fibro-
blasts. Apparently, expression of P90 is suffi-
cient. 
Several rescued viruses contained new se-
quences at the 3' end, but the restriction sites 
seen did not suggest the addition of normal 
helper sequences as was found in most of the 
cases. Many explanations for these unusual pro-
viruses are possible. One possibility is that the 
helper virus parent of these recombinants may 
have been a variant with an unusual 3' end 
(lacking one of the sites expected). Sites would 
then be detected which do not all fall into the 
pattern seen with a normal helper virus. 
It is also possible that no LTR is in fact 
present at the 3' end of these variant proviruses. 
Rescue and subsequent integration of the A-
MuL V genome would have had to occur by an . 
aberrant process not yielding a normal proviral 
structure. Rescue from primary foci was such a 
rare event, however, that very infrequent pro-
cesses (such as aberrant integrations) could ac-
count for the observed frequency. This possibili-
ty is strengthened by the finding that at least 
some of these aberrant clones were not high-
level producers of A-MuL V (Table 2). Thus, an 
independent functional test suggests that at least 
part of the structure needed for normal transmis-
sibility was not present. At some low frequency, 
virus infection apparently resulted in integration 
of aberrant proviruses. 
These aberrant secondary proviruses were not 
found in the initial discovery of the rescue 
process described by Goldfarb and Weinberg 
(13). Only four independent isolates were ana-
lyzed in that work and thus statistically it is 
possible that no aberrant proviruses were de-
tected. However, proviruses in secondary foci 
were not directly analyzed; rather, nonproducer 
transformed cell lines (tertiary lines) were de-
rived by infection with the virus released from 
the secondary foci (13). The RNA in these 
nonproducer lines was studied. Thus, if aberrant 
secondary proviruses were formed in that work 
they might have been repaired during transfer to 
the tertiary cells. 
Further analysis of the RNA produced by 
these cells and of the proviruses in tertiary foci 
should determine whether L TRs are present and 
if so, whether they are transmitted without 
change to new cells during subsequent passages. 
Efliciency of transfection. The direct transfec-
tion of A-MuLV DNA into NIH/3T3 cells occurs 
with very low efficiency compared with that of 
other selectable DNAs (Table 1). A few foci 
were recovered, but large numbers of cells and 
large amounts of DNA were required. The aber-
rant permuted structure of the DNA did not 
seem to be responsible for the low efficiency, 
since dimerization which reconstructed a com-
plete provirus did not improve the yield. Vector 
sequences were also not responsible. Cotrans-
fection of the dimeric A-MuLV DNA with provi-
ral helper M-MuLV DNA, however, resulted in 
an enormous stimulation in the number of foci 
recovered. Apparently virus could be rescued 
from cells which would not otherwise have been 
stably transformed and transmitted as pseudo-
typed genomes to new cells. The process could 
occur without the 3' end of the A-MuLV genome 
but was carried out most efficiently when com-
plete A-MuLV DNA was used. 
We favor the hypothesis that a large number 
of A-MuL V genomes is typically introduced into 
recipient cells by DNA transfection. This large 
number may be due to the direct introduction of 
many copies or to amplification of the intro-
duced DNA once it has entered the cell via 
transfection. We speculate as well that the multi-
ple copies of A-MuL V are toxic to the cell and 
that most cells transfected with Abl DNA are 
inviable. Thus, the consequences of most suc-
cessful gene transfers are obscured by the death 
of the transfected cells. Transfection is much 
more efficiently registered if the acquired A-
MuL V is rescued from the transfected cell be-
fore it dies and is introduced by helper virus into 
neighboring cells. These neighboring cells ac-
quire low numbers of A-MuLV by infection and 
are therefore able to grow out into transformed 
colonies. Such a mechanism explains as well the 
inhibitory effects of A-MuLV on the cotransfect-
ed pSV2-gpt cloned DNA. We suggest that both 
cotransfected DNAs become amplified in a re-
cipient cell and that this cell is killed by the 
multiple A-MuL V genomes. 
It is likely that tne toxic effect is mediated by 
expression of the P90 protein and is not a direct 
effect of the A-MuL V DNA because inactive 
clones and fragmented clones (Table 4) did not 
show the effect. The presence of large amounts 
of P90 and its associated kinase activity may 
cause a drastic disruption of cellular metabolic 
control. 
The transfection of total cellular DNA isolated 
from A-MuLV-transformed cells has been re-
cently described (16). In these experiments, the 
transfected cells were passaged many times be-
fore a final plating and scoring for the appear-
ance of foci. Thus, the efficiency of the actual 
transfection procedure could not be determined. 
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The number of foci seen, however, is not incon-
sistent with our results. Recently a cloned provi-
rus copy of the A-MuL V genome was used by 
others to transform NIH/3T3 cells (31) and was 
found to show high-efficiency transformation 
even without helper virus. We have obtained 
this clone and tested the efficiency of transfor-
mation under our conditions. Both the low effi-
ciency and the stimulation upon addition of M-
MuLV DNA were identical to those obtained 
with our cloned DNA. Thus the recipient cells or 
the conditions of transfection must be responsi-
ble for the difference in results between the 
laboratories. 
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